September 13, 2023: Endpoints News - MaaT Pharma and CDMO Skyepharma unveil bespoke, and potentially largest, microbiome facility in Europe - MaaT Pharma

To read the article, click here!

Previous PostSeptember 19, 2023: Le Point - Traitement des cancers : le microbiote intestinal passe en phase industrielle (French only)
Next PostSeptember 12, 2023: MaaT Pharma and Skyepharma Complete Construction of Europe’s Largest Manufacturing Facility for Microbiome Ecosystem Therapies

© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

MaaT Pharma dans les médias MaaT Pharma in the News Devenez membre du club Become a member of the club